Connection

Co-Authors

This is a "connection" page, showing publications co-authored by WENDY WOODWARD and MICHAEL C. STAUDER.
Connection Strength

3.325
  1. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys. 2016 11 01; 96(3):637-44.
    View in: PubMed
    Score: 0.576
  2. Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement. Int J Radiat Oncol Biol Phys. 2022 07 01; 113(3):552-560.
    View in: PubMed
    Score: 0.213
  3. How should radiation be done for inflammatory breast cancer patients?-a narrative review of modern literature. Chin Clin Oncol. 2021 Dec; 10(6):60.
    View in: PubMed
    Score: 0.209
  4. Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach. Pract Radiat Oncol. 2019 Nov; 9(6):402-409.
    View in: PubMed
    Score: 0.176
  5. Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects. Cancers (Basel). 2018 Apr 07; 10(4).
    View in: PubMed
    Score: 0.162
  6. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer. 2018; 9(8):1437-1447.
    View in: PubMed
    Score: 0.162
  7. A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer. Adv Radiat Oncol. 2018 Jul-Sep; 3(3):252-257.
    View in: PubMed
    Score: 0.161
  8. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. J Cancer. 2017; 8(11):2026-2032.
    View in: PubMed
    Score: 0.154
  9. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer. 2015 Dec 15; 121(24):4324-32.
    View in: PubMed
    Score: 0.136
  10. Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol. 2015 Jul-Aug; 5(4):e283-90.
    View in: PubMed
    Score: 0.131
  11. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus. 2015; 4:36.
    View in: PubMed
    Score: 0.130
  12. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus. 2014; 3:166.
    View in: PubMed
    Score: 0.123
  13. Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer. Pract Radiat Oncol. 2023 Oct 31.
    View in: PubMed
    Score: 0.060
  14. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast. 2023 Apr; 68:205-215.
    View in: PubMed
    Score: 0.057
  15. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol. 2022 Oct; 29(10):6381-6392.
    View in: PubMed
    Score: 0.055
  16. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat. 2022 Aug; 195(1):33-41.
    View in: PubMed
    Score: 0.055
  17. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol. 2022 Mar-Apr; 7(2):100877.
    View in: PubMed
    Score: 0.053
  18. Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):426-436.
    View in: PubMed
    Score: 0.052
  19. Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):437-444.
    View in: PubMed
    Score: 0.052
  20. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys. 2021 10 01; 111(2):360-370.
    View in: PubMed
    Score: 0.050
  21. Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):441-448.
    View in: PubMed
    Score: 0.048
  22. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist. 2020 06; 25(6):e990-e992.
    View in: PubMed
    Score: 0.047
  23. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. Int J Radiat Oncol Biol Phys. 2019 07 01; 104(3):574-581.
    View in: PubMed
    Score: 0.043
  24. Association of Transforming Growth Factor ? Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2018 12 01; 4(12):1751-1757.
    View in: PubMed
    Score: 0.042
  25. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol. 2018 Oct 31; JCO1800317.
    View in: PubMed
    Score: 0.042
  26. Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncol. 2018 09 01; 4(9):1207-1213.
    View in: PubMed
    Score: 0.042
  27. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer. Surg Clin North Am. 2018 Aug; 98(4):787-800.
    View in: PubMed
    Score: 0.041
  28. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol. 2017 Oct; 24(10):2965-2971.
    View in: PubMed
    Score: 0.039
  29. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):291-300.
    View in: PubMed
    Score: 0.038
  30. Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. Lancet Oncol. 2017 04; 18(4):e228-e232.
    View in: PubMed
    Score: 0.038
  31. Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation. Cancer. 2016 09 15; 122(18):2886-94.
    View in: PubMed
    Score: 0.036
  32. Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly? Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):49-51.
    View in: PubMed
    Score: 0.036
  33. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol. 2015 Oct; 1(7):931-41.
    View in: PubMed
    Score: 0.034
  34. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):102-10.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.